American Cancer Society update: ‘It is best not to drink alcohol’June 9, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerLymphoma & Plasma Cell DisordersOncology
Can an app guide cancer treatment decisions during the pandemic?June 9, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
‘A good and peaceful death’: Cancer hospice during the pandemicJune 5, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Germline testing in advanced cancer can lead to targeted treatmentJune 3, 2020Mixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanomaOncology
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unitMay 26, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersLung CancerMixed Topics
Low-dose erlotinib seems feasible for frail, elderly patients with NSCLCMay 26, 2020Lung CancerOncology
ASCO goes ahead online, as conference center is used as hospitalMay 11, 2020Mixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell Disorders
FDA approves selpercatinib for lung and thyroid RET tumorsMay 11, 2020Lung CancerHead & Neck/Thyroid Cancers
COVID-19 death rate was twice as high in cancer patients in NYC studyMay 5, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
